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SUMMARY
Background：Neurons containing enkephalin（ENK）are distributed at high concentrations in the super­
ficial dorsal horn（SDH）of the spinal cord, where they play an important role in the modulation of nocicep­
tive information. In addition to ENK, the SDH exhibits high expression levels of the NR2B subunit of the 
N-methyl-d-aspartate（NMDA）receptor and large-conductance calcium-activated potassium（BK）chan­
nels. In the present behavioral experiments, we investigated the effects of the BK channel antagonist cha­
rybdotoxin（CTX）and the NR2B subunit antagonist ifenprodil（IFN）on a nociceptive behavior in peripher­
al-nerve-injured mice.
Methods：The experiments were performed in 6- to 8-week-old male ICR mice. Partial sciatic nerve 
ligation（PSL）was performed as described previously（Seltzer model）. Mechanical allodynia was assessed 
by stimulation with von Frey filaments. On postsurgical day 7, the effects of CTX and IFN on mechanical 
allodynia were analyzed. Additionally, to test the possibility that the actions of CTX and IFN are mediated 
by an altered release of ENK, we investigated the effect of the selective m- and d-opioid receptor antago­
nists naloxone（NAL）and naltrindole（NTL）, respectively. CTX（1 pmol/10 mL per mouse）, IFN（50 
nmol/10 mL per mouse）, and saline as a control（10 mL per mouse）were intrathecally injected. Additionally, 
NAL（5 mg/kg）and NTL（5 mg/kg）were intraperitoneally administered. All behavioral experiments were 
performed in a double-blind fashion.
Results：PSL significantly increased the occurrence of the withdrawal reflex to von Frey stimuli, indicat­
ing the development of mechanical allodynia. CTX significantly reduced the occurrence of the withdrawal 
reflex compared to the saline group. Additionally, both NAL and NTL attenuated the analgesic effect of 
CTX. Intrathecal IFN significantly reduced the occurrence of the withdrawal reflex, which was also 
reduced by NAL and NTL.
Conclusion：The obtained behavioral observations suggest that the NMDA receptors and BK channels 
might inhibit the release of ENK in the SDH, which is speculated to be involved in the chronic pain state 
induced by peripheral nerve injury.
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INTRODUCTION
Enkephalins（ENKs）are pentapeptides（Tyr-Gly-
Gly-Phe-Met or Tyr-Gly-Gly-Phe-Leu）that are 
derived from the precursor preproenkephalin. ENKs 
are involved in many physiological functions, including 
modulation of nociceptive perception, regulation of 
memory, emotional condition, food and liquid consump­
tion, and regulation of the immunological response 1）.
ENK-containing neurons are widely distributed in 
the central nervous system. One of these regions 
includes the superficial dorsal horn（SDH）of the spi­
nal cord 2〜4）. Here, ENK-containing neurons play an 
important role in regulating the transmission of noci­
ceptive information 1,5,6）.
Several other groups of investigators and we have 
generated a transgenic mouse using an artificial bacte­
rial chromosome, which expresses the green fluores­
cent protein（GFP）under the control of the preproen­
kepha l in promoter 7〜9）. Us ing such ENK-GFP 
transgenic mice, we have electrophysiologically char­
acterized the ENK-containing SDH neuron 7）. Howev­
er, it remains unclear how the activity of the ENK-
containing neuron is regulated in the SDH.
In addition to ENK, the SDH contains a high con­
centration of N-methyl-d-aspartate（NMDA）subtype 
glutamate receptors 10〜12）. These receptors are mostly 
involved in the modulation of nociceptive transmission 
in the SDH. It has been reported that the NR2B sub­
unit of NMDA receptors is upregulated, which is asso­
ciated with the development of neuropathic pain 10,11）. 
Furthermore, calcium-activated large-conductance 
potassium（BK）channels exhibit high-density distri­
bution in the SDH and are involved in the nociceptive 
modulation 13〜16）.
Recently, Song and Marvizón measured the inter­
nalization of m-opioid receptors and suggested that 
the Ca 2＋ entering through activated NMDA receptors 
opens BK channels, resulting in the hyperpolarization 
of ENK-containing neurons, and thus, leading to a 
decrease in ENK release in the SDH17）. Furthermore, 
electrophysiological investigation has suggested that 
NMDA receptors interact with BK channels, which 
leads to hyperpolarization of neurons in several 
regions of the central nervous system, including the 
olfactory bulb 18）and hippocampus 19）. As such, the 
present behavioral experiments investigate whether 
NMDA receptors, interacting with BK channels, are 
involved in the regulation of ENK release in the SDH.
Our results show that intrathecal（i.t.）administra­
tion of a BK channel antagonist or an NMDA receptor 
antagonist has an antinociceptive effect, which is 
blocked by intraperitoneal（i.p.）administration of opi­
ate receptor antagonists. These findings provide clues 
to understand further how the activity of ENK-con­
taining neurons in the spinal dorsal horn is regulated. 
Additionally, the findings reveal information regarding 
the pathophysiological mechanisms of the develop­
ment of neuropathic pain induced by peripheral nerve 
injury.
METHODS
Animals
Experiments were performed on 6- to 8-week-old 
male ICR mice. The mice were maintained at con­
trolled room temperature under a 12 h/12 h light/
dark cycle. All animal experiments were approved by 
the Institutional Animal Care and Use Committees at 
Dokkyo Medical University. The animals were treated 
in accordance with the National Institutes of Health 
guidelines on animal care and the International Asso­
ciation for the Study of Pain 20）.
Neuropathic pain model
The sciatic nerve was partially ligated of the mice 
while anesthetized with sevoflurane as previously 
described（partial sciatic nerve ligation ［PSL］, Seltzer 
model）21）. In sham-operated control mice, the sciatic 
nerve was exposed but not ligated.
Behavioral assessment of mechanical allodynia
To assess nociceptive behavior associated with sci­
atic nerve ligation, we measured the frequency of 
withdrawal responses to 10 repetitive stimuli with 
von Frey filaments（Stoeling, USA）using 0.16 g of 
force.
Behavioral assessments were performed one day 
prior to the ligation surgery. On postsurgical day 7, 
the frequency of withdrawal responses significantly 
increased, indicating the development of mechanical 
allodynia induced by peripheral nerve injury. On this 
day, the effects of the BK channel antagonist charyb­
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dotoxin（CTX）and the NR2B antagonist ifenprodil
（IFN）on nociceptive behavior were analyzed.
Chemicals used
The following chemicals were injected intrathecally 
according to the modified method originally described 
by Hylden et al.（1980）22）：CTX, a specific antagonist 
to BK channels（1 pmol/10 mL per mouse）13）；IFN, a 
specific antagonist to the NR2B subtype of NMDA 
receptors（50 nmol/10 mL per mouse）23,24）；and saline 
as a control（10 mL per mouse）.
Withdrawal tests were performed 15 minutes after 
i.t. administration of IFN or CTX when the effects of 
the drugs were maximal（the label ‘During i.t.’ on the 
horizontal axis in Figure 1 and 3）. Recovery from IFN 
or CTX was evaluated 90 minutes after i.t. administra­
tion of the drugs（the label ‘After i.t.’ on the horizontal 
axis in Figure 1 and 3）.
To also address the possibility that the actions of 
CTX and IFN are mediated by an alteration in the 
release of ENK, we investigated the effect of the 
selective d-opioid receptor antagonist naltrindole
（NTL, 5 mg/kg body weight）and the m-opioid recep­
tor antagonist naloxone（NAL, 5 mg/kg body weight）, 
which were both injected intraperitoneally.
All behavioral experiments were performed in a 
double-blind setting.
Statistical analysis
Results are expressed as the mean±SEM. Statisti­
cal analysis was performed by conducting a two-way 
repeated measurements analysis of variance（ANOVA）, 
with one between-group “antagonist” factor（antago­
nist/saline）and one within-subject “time” factor
（before/during/after）. When the antagonist-by-time 
interaction was significant, additional within-group 
effects were determined by a test for simple main 
effects. One-way ANOVA with Tukey’s post hoc com­
Figure 1　Attenuation of mechanical allodynia by 
intrathecal IFN
The vertical axis indicates the frequency of hindlimb-
withdrawal response to von Frey stimuli.
Values in parentheses represent the number of obser­
vations in each group.
“†” indicates a significant difference between the 
IFN and saline group, with p ＜ 0.05.
“＊” indicates a significant difference compared to 
before and during the i.t. injection, with p ＜ 0.05.
“ns” indicates no significant difference.
Figure 2　Reversal of the analgesic effect of intrathecal 
IFN by intraperitoneal administration of NTL（blue 
bar）and NAL（green bar）
The vertical axis indicates the frequency of hindlimb-
withdrawal response to von Frey stimuli.
“＊” indicates a significant difference between the three 
treatment groups, with p ＜ 0.05.
“ns” indicates no significant difference.
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parisons among three to four treatment groups was 
also used when appropriate. Comparisons with a dif­
ference of p ＜ 0.05 were considered statistically sig­
nificant.
RESULTS
Attenuation of mechanical allodynia by i.t. IFN and its 
reversal by i.p. NAL and NTL
The i.t. administration of IFN ameliorated mechani­
cal allodynia reversibly, as shown in Figure 1 . To 
evaluate the possibility that the analgesic action of 
IFN was mediated by an increased release of ENK, 
the effect of i.p. administration of the selective d-opi­
oid receptor antagonist NTL and the selective m- 
opioid receptor antagonist NAL were investigated. 
Here, Figure 2 shows that the analgesic effect of i.t. 
IFN was reduced by i.p. injection of NAL（green bar）
and NTL（blue bar）.
Attenuation of mechanical allodynia by i.t. CTX and 
its reversal by i.p. NAL and NTL
The i.t. administration of CTX ameliorated mechani­
cal allodynia reversibly, as shown in Figure 3. The 
effect of i.p. NTL and i.p. NAL on i.t. CTX was investi­
gated to address the possibility that the analgesic 
action of CTX was mediated by an increased release 
of ENK. Here, the results showed that the analgesic 
action of i.t. CTX was reduced by i.p. NAL（green bar 
in Figure 4）and i.p. NTL（blue bar in Figure 4）.
The i.t. coadministration of CTX and IFN did not 
show any synergic antinociceptive effect.
Previous studies have shown that BK channels in 
neurons in various regions of the central nervous sys­
tem are activated by Ca 2＋ influx through NMDA 
receptors, which then leads to the hyperpolarization 
of neurons 18,19）. To determine if i.t. IFN-induced anal­
gesia is mediated by inhibition of BK channels in 
Figure 3　Attenuation of mechanical allodynia by 
intrathecal CTX
The vertical axis indicates the frequency of 
hindlimb-withdrawal response to von Frey stimuli.
“†” indicates a significant difference between the 
CTX and saline group, with p ＜ 0.05.
“＊” indicates a significant difference compared to 
before i.t. injection, with p ＜ 0.05.
“ns” indicates no significant difference.
Figure 4　Reversal of the analgesic effect of intrathecal 
CTX by intraperitoneal administration of NTL（blue bar）
and NAL（green bar）
The vertical axis indicates the frequency of hindlimb-
withdrawal response to von Frey stimuli.
“＊” indicates a significant difference between the three 
treatment groups, with p ＜ 0.05.
“ns” indicates no significant difference.
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ENK-containing neurons in the SDH, we investigated 
whether i.t. coadministration of CTX and IFN exhibits 
any synergic antinociceptive actions. The results 
showed that simultaneous i.t. administration of CTX 
and IFN attenuated mechanical allodynia（purple bar 
in Figure 5）to the same extent as CTX and IFN 
alone（green and red, respectively, in Figure 5）.
DISCUSSION
Analgesic effect of i.t. IFN and its involvement of ENK 
release
The present experiments showed that i.t. injection 
of the NR2B antagonist IFN attenuated mechanical 
allodynia induced by peripheral nerve injury and that 
this action was blocked by i.p. administration of the 
opioid receptor antagonists NAL and NTL.
The antinociceptive action of the i.t. NR2B antago­
nist has previously been reported 23,24）. For example, 
Kim et al. reported that i.t. administration of IFN（100, 
200 , 500 , and 1000 nmol）increased the paw with­
drawal threshold in a neuropathic model mouse 23）.
Peripheral nerve injury upregulates the NR2B sub­
unit of NMDA receptors in the SDH10,11）, resulting in 
an increased excitability of the spinal interneurons, 
which in turn underlies the mechanisms for the neu­
ropathic pain state 10〜12）. Here, several studies have 
suggested that the i.t. NR2B antagonist suppresses 
the excitability of the SDH neural circuit, and there­
fore, exerts analgesic actions 23,24）.
In addition to this analgesic mechanism of the 
NR2B antagonist, the present observations seem to 
indicate that at least a part of the analgesic action of 
the i.t. NR2B antagonist might lead to an increase in 
ENK release and the activation of opioid receptors in 
the SDH.
Analgesic effect of i.t. CTX and its involvement of 
ENK release
The i.t. injection of the BK channel blocker CTX 
was observed to exert inhibitory actions on mechani­
cal allodynia. Moreover, this action was blocked by i.p. 
administration of the opioid receptor antagonists NAL 
and NTL.
Along the same lines as our present observations, 
i.t. BK channel blocker has been reported to signifi­
cantly inhibit tactile allodynia induced by nerve inju­
ry 13）. However, in a study by Chen et al. , it was 
reported that the activation of BK channels reversed 
allodynia and hyperalgesia caused by nerve injury 14）. 
Although the exact reason for this discrepancy 
remains currently unclear, the BK channels in the 
SDH do seem to play an important role in the modula­
tion of nociceptive information.
BK channels assume various roles in the central 
nervous system15）. For example, it was shown that 
the activation of BK channels in the spinal cord inhib­
its the release of the inhibitory neurotransmitter gly­
cine from spinal interneurons 25）. Hence, it is reason­
able to speculate that a BK channel blocker, such as 
CTX, would enhance the release of the inhibitory neu­
rotransmitter ENK from spinal ENK-containing inter­
neurons.
Figure 5　No synergy between the analgesic effects of 
intrathecal CTX and IFN
The vertical axis indicates the frequency of hindlimb-
withdrawal response to von Frey stimuli.
“＊” indicates a significant difference between the four 
treatment groups, with p ＜ 0.05.
Blue bar：i.t. saline group. Purple bar：i.t. coadministra­
tion of the CTX and IFN group. Green bar：i.t. CTX 
only group. Red bar：i.t. IFN only group.
“ns” indicates no significant difference.
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Possible interaction of the NR2B subunit NMDA 
receptors with the BK channels in the SDH
The blocking of BK channels by i.t. CTX negated 
the effects of i.t. IFN in the present experiments. Fur­
thermore, the analgesic action of both i.t. IFN and i.t. 
CTX might involve an increased release of ENK in 
the SDH.
Based on these findings, it is speculated that IFN 
inhibits NMDA receptors, and thus, reduces Ca 2＋ 
influx through the NMDA receptor, which then 
results in the inhibition of the BK channels, leading to 
depolarization of ENK neurons. Depolarization of ENK 
neurons results in an increase of ENK release in the 
SDH, which might underlie the mechanism of the 
presently observed antinociceptive actions of IFN and 
CTX.
The coupling between the NMDA receptors and 
the BK channels in neurons has been found in various 
regions of the central nervous system, including the 
olfactory bulb 18）and the hippocampus 19）. For example, 
neurons in the olfactory bulb hyperpolarize in 
response to the activation of NMDA receptors 18）. This 
hyperpolarization is mediated by the BK channel 
opening caused by the influx of Ca 2＋ through activat­
ed NMDA receptors.
Although it is not yet clear whether the coupling 
between NMDA receptors and BK channels exists in 
ENK-containing neurons in the SDH, the present 
behavioral results might indicate that this is the case. 
This speculation is supported by a study of Song et al., 
where they reported that the m-opioid receptor inter­
nalization was inhibited by the activation of NMDA 
receptors in rat spinal cord slices ─ in which the inter­
nalization of m-opioid receptors reflects the release of 
opioids ─ and that the inhibition was blocked by a BK 
channel blocker 17）.
Conclusions
The present findings of this study strongly suggest 
that Ca 2＋ influx through NMDA receptors opens the 
BK channels, causing the hyperpolarization of inhibito­
ry interneurons in the SDH. In turn, this causes a 
decrease in release of inhibitory transmitters such as 
ENK. In support to these findings, the NR2B subunit 
of NMDA receptors has been shown to be upregulat­
ed in the neuropathic pain state 10,11）. NMDA-recep­
tor-mediated hyperpolarization of inhibitory interneu­
rons in the SDH might contribute to the hyperalgesic 
actions of spinal NMDA receptors. Finally, further 
investigation is required to clarify whether immediate 
coupling between NMDA receptors and BK channels 
exists in inhibitory interneurons in the SDH.
Acknowledgments．This study was supported in 
part by the JSPS KAKENHI Grant Number JP18K 
16462（EK）.
Conﬂict of interest
The authors state that they have no conflict of 
interest.
REFERENCES
 1） Russell JA, Douglas AJ：Opioids. In：Fink G Ed, 
Encyclopedia of Stress. San Diego Academic Press 
86-89, 2000.
 2） Bennett GJ, Ruda MA, Gobel S, et al.：Enkephalin 
immunoreactive stalked cells and lamina IIb islet 
cells in cat substantia gelatinosa. Brain Res 240：
162-166, 1982.
 3） Glazer EJ, Basbaum AI：Immunohistochemical local­
ization of leucine-enkephalin in the spinal cord of the 
cat：enkephalin-containing marginal neurons and 
pain modulation. J Comp Neurol 196：377-389, 1981.
 4） Hokfelt T, Elde R, Johansson O, et al.：The distribu­
tion of enkephalin-immunoreactive cell bodies in the 
rat central nervous system. Neurosci Lett 5：25-31, 
1977.
 5） Hossaini M, Duraku LS, Kohli SK, et al.：Spinal distri­
bution of c-Fos activated neurons expressing 
enkephalin in acute and chronic pain models. Brain 
Res 1543：83-92, 2014.
 6） Basbaum AI, Fields HL：Endogenous pain control 
systems：brainstem spinal pathways and endorphin 
circuitry. Annu Rev Neurosci 7：309-338, 1984.
 7） Fukushima T, Tsuda M, Kofuji T, et al.：Physiologi­
cal properties of enkephalin-containing neurons in 
the spinal dorsal horn visualized by expression of 
green fluorescent protein in BAC transgenic mice. 
BMC Neurosci 12：36, 2011.
 8） Huang J, Chen J, Wang W, et al.：Expression pattern 
of enkephalinergic neurons in the developing spinal 
cord revealed by preproenkephalin-green fluorescent 
NMDA receptors inhibit enkephalin neurons46（1）（2019） 7
protein transgenic mouse and its colocalization with 
GABA immunoreactivity. Cells Tissues Organs 193：
404-416, 2011.
 9） Koshimizu Y, Wu SX, Unzai T, et al.：Paucity of 
enkephalin production in neostriatal striosomal neu­
rons：analysis with preproenkephalin-green fluores­
cent protein transgenic mice. Eur J Neurosci 28：
2053-2064, 2008.
 10） Iwata H, Takasusuki T, Yamaguchi S, et al.：NMDA 
receptor 2B subunit-mediated synaptic transmission 
in the superficial dorsal horn of peripheral nerve-
injured neuropathic mice. Brain Res 1135：92-101, 
2007.
 11） Zhou HY, Chen SR, Pan HL：Targeting N-methyl-
D-aspartate receptors for treatment of neuropathic 
pain. Expert Rev Clin Pharmacol 4：379-388, 2011.
 12） Gao X, Kim HK, Chung JM, et al.：Enhancement of 
NMDA receptor phosphorylation of the spinal dorsal 
horn and nucleus gracilis neurons in neuropathic 
rats. Pain 116：62-72, 2005.
 13） Hayashi Y, Kawaji K, Sun L, et al.：Microglial Ca
（2＋）-activated K（＋）channels are possible molecu­
lar targets for the analgesic effects of S-ketamine on 
neuropathic pain. J Neurosci 31：17370-17382, 2011.
 14） Chen SR, Cai YQ, Pan HL：Plasticity and emerging 
role of BKCa channels in nociceptive control in neu­
ropathic pain. J Neurochem 110：352-362, 2009.
 15） Contet C, Goulding SP, Kuljis DA, et al.：BK Chan­
nels in the Central Nervous System. Int Rev Neurobi­
ol 128：281-342, 2016.
 16） Furukawa N, Takasusuki T, Fukushima T, et al.：
Presynaptic large-conductance calcium-activated 
potassium channels control synaptic transmission in 
the superficial dorsal horn of the mouse. Neurosci 
Lett 444：79-82, 2008.
 17） Song B, Marvizón JC：N-methyl-D-aspartate recep­
tors and large conductance calcium-sensitive potassi­
um channels inhibit the release of opioid peptides 
that induce mu-opioid receptor internalization in the 
rat spinal cord. Neuroscience 136：549-562, 2005.
 18） Isaacson JS, Murphy GJ：Glutamate-mediated extra­
synaptic inhibition：direct coupling of NMDA recep­
tors to Ca（2＋）-activated K＋ channels. Neuron 
31：1027-1034, 2001.
 19） Zhang J, Guan X, Li Q, et al.：Glutamate-activated 
BK channel complexes formed with NMDA recep­
tors. Proc Natl Acad Sci U S A 115：E9006-E9014, 
2018.
 20） Zimmermann M：Ethical guidelines for investigations 
of experimental pain in conscious animals. Pain 16：
109-110, 1983.
 21） Seltzer Z, Dubner R, Shir Y：A novel behavioral 
model of neuropathic pain disorders produced in rats 
by partial sciatic nerve injury. Pain 43：205-218, 
1990.
 22） Hylden JL, Wilcox GL：Intrathecal morphine in 
mice：a new technique. Eur J Pharmacol 67：313-
316, 1980.
 23） Kim Y, Cho HY, Ahn YJ, et al.：Effect of NMDA 
NR2B antagonist on neuropathic pain in two spinal 
cord injury models. Pain 153：1022-1029, 2012.
 24） Zhang W, Shi CX, Gu XP, et al.：Ifenprodil induced 
antinociception and decreased the expression of 
NR2B subunits in the dorsal horn after chronic dor­
sal root ganglia compression in rats. Anesth Analg 
108：1015-1020, 2009.
 25） Shoudai K, Nonaka K, Maeda M, et al.：Effects of 
various K＋ channel blockers on spontaneous glycine 
release at rat spinal neurons. Brain Res 1157：11-22, 
2007.
